{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:44:58Z","timestamp":1747183498260,"version":"3.40.5"},"reference-count":51,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T00:00:00Z","timestamp":1686096000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>To compare the gestational age of neonates in utero exposed to benzodiazepines (BDZs) with nonexposed controls. Secondary objectives were birth weight, presence of congenital malformations, APGAR score and the need for &gt;3\u2009months (prolonged) maternal psychiatric care.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective cohort study of women and neonates from 2013 to 2021 with univariate and multivariable analysis to study the associations between BDZ exposure and gestational age compared to nonexposed women with mental health problems.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We found that BDZ exposure was not associated with a lower gestational age. We found that women in the exposed group had an increased risk of psychiatric care (adjusted odds ratio 2.58 [95% confidence interval 1.71\u20133.91], <jats:italic>P<\/jats:italic>\u00a0&lt;\u2009.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We found that in utero BDZ exposure was not associated with a significantly lower gestational age of the neonates and was associated with prolonged psychiatric care of their mothers.<\/jats:p><\/jats:sec>","DOI":"10.1111\/bcp.15795","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T04:34:13Z","timestamp":1684816453000},"page":"3005-3015","source":"Crossref","is-referenced-by-count":1,"title":["Maternal and neonatal outcomes after benzodiazepine and benzodiazepine agonist exposure during pregnancy in women with mental disorders"],"prefix":"10.1111","volume":"89","author":[{"given":"Hennique","family":"Knobbe","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy Isala  Zwolle The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elvera A.","family":"Damer","sequence":"additional","affiliation":[{"name":"Department of Psychiatry Isala  Zwolle The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireille A.","family":"Edens","sequence":"additional","affiliation":[{"name":"Isala Academie Isala  Zwolle The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bas S. W. A.","family":"Nij Bijvank","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics Isala  Zwolle The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marieke A. C.","family":"Hemels","sequence":"additional","affiliation":[{"name":"Department of Neonatology Isala  Zwolle The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1914-5907","authenticated-orcid":false,"given":"Peter G. J.","family":"ter Horst","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy Isala  Zwolle The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,6,7]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00404\u2010019\u201005075\u20102"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2013.279"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12884\u2010019\u20102572\u20104"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2007.10.007"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00737\u2010005\u20100090\u2010z"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.03.014"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.53.1.39"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1177\/0706743720904860"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2022.104647"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1701\u20102163(16)34772\u20107"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.317.7162.839"},{"key":"e_1_2_11_13_1","article-title":"Benzodiazepinegebruik in de zwangerschap","volume":"1","author":"NVOG (Nederlandse Vereniging voor Obstetrie en Gynaecologie)","year":"2013","journal-title":"Feder Med Special: Richtlijndatabase"},{"key":"e_1_2_11_14_1","unstructured":"(NVOG) NV voor O en G.Benzodiazepinegebruik in de zwangerschap.2013. Fed med spec richtlijndatabase 2013. Published 2013. Accessed October 7 2020.https:\/\/lkpz.nl\/docs\/lkpz_pdf_1398241285.pdf"},{"key":"e_1_2_11_15_1","unstructured":"Service TI.Geneesmiddelgebruik rondom de zwangerschap. Bijwerkingencentrum Lareb."},{"key":"e_1_2_11_16_1","unstructured":"Organization WH.ICD\u201010: International statistical classification of diseases and related health problems.2014;Tenth revi."},{"key":"e_1_2_11_17_1","unstructured":"EUROCAT.EUROCAT Guide 1. 4 and Reference Documents (Last update version 28\/12\/2018).2013."},{"key":"e_1_2_11_18_1","first-page":"1","volume-title":"Determinants and Prevention of Low Birth Weight: A Synopsis of the Evidence","author":"Ohlsson A","year":"2008"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/1047\u20102797(94)90082\u20105"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j4511"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889\u2010021\u201011185\u2010x"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00404\u2010018\u20104833\u20102"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170946"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2013.684"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471\u2010244X\u20106\u201012"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/appy.12309"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1457"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.5860"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2012.09.003"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2020.105243"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(08)60074\u20104"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2015.09.007"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajo.12143"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2017.01.008"},{"key":"e_1_2_11_35_1","unstructured":"RStudio Team.RStudio.2020.http:\/\/www.rstudio.com"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyw341"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471\u20102288\u20108\u201070"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040297"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2018.12.032"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.97"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.18r12412"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mimet.2013.05.008"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00659"},{"key":"e_1_2_11_44_1","unstructured":"EUROCAT.Prevalence charts and tables.2018."},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/OGX.0000000000000405"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1080\/09595230600944461"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1741\u20104520.2010.00310.x"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu738"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1499"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2019.0963"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043462"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12884\u2010019\u20102572\u20104"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.15795","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T06:10:50Z","timestamp":1698041450000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.15795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,7]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1111\/bcp.15795"],"URL":"https:\/\/doi.org\/10.1111\/bcp.15795","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"type":"print","value":"0306-5251"},{"type":"electronic","value":"1365-2125"}],"subject":[],"published":{"date-parts":[[2023,6,7]]}}}